首頁 > 市場調查報告書 > 製藥

消化器

制酸劑市場規模、佔有率和成長分析（按類型、劑型、通路、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1919114

制酸劑市場規模、佔有率和成長分析（按類型、劑型、通路、最終用戶和地區分類）－2026-2033年產業預測

Antacids Market Size, Share, and Growth Analysis, By Type (Calcium Carbonate, Magnesium Hydroxide), By Formulation (Tablets, Liquid / Suspension), By Distribution Channel, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年01月02日 | 出版商:

SkyQuest | 英文 171 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球制酸劑市場規模將達到 102 億美元，到 2025 年將達到 107.7 億美元，到 2033 年將達到 166.6 億美元，預測期（2026-2033 年）的複合年成長率為 5.6%。

全球制酸劑市場預計將迎來顯著成長，這主要得益於人們對胃食道逆流症 (GERD) 的認知不斷提高，以及能夠快速緩解症狀的非處方 (OTC)制酸劑的日益普及。人口老化加劇了老年人對酸相關疾病的易感性，加上人們獲取膳食資訊的管道日益增多，進一步推動了市場需求。生活方式的改變，例如壓力、肥胖、吸煙和飲酒，導致酸相關疾病的發病率迅速上升，給醫療保健專業人員帶來了挑戰。此外，老年患者中巴瑞特氏食道症等嚴重的盛行率不斷上升，促使人們尋求不同的治療方法，而制酸劑在其中發揮關鍵作用。非處方產品的持續流行反映了消費者對快速緩解灼熱和消化不良的偏好，也推動了市場向前發展。

推動全球制酸劑市場發展的因素

全球制酸劑市場的主要促進因素之一是胃食道逆流症 (GERD) 及其他相關胃腸道疾病的日益普遍。不健康的飲食習慣和久坐的生活方式正在推高酸相關疾病的發生率，並增加人們對有效緩解症狀的需求。此外，消費者對消化系統健康的日益關注也推動了對制酸劑的需求，因為這類藥物能夠快速且方便地緩解症狀。隨著醫療保健專業人員不斷強調控制酸相關症狀的重要性，預計這些因素將顯著推動制酸劑市場的成長。

全球制酸劑市場限制因素

全球制酸劑市場的主要限制因素之一是消費者對長期服用此類藥物潛在副作用的認知不斷提高。隨著消費者對腎臟問題和營養吸收受損等風險的了解加深，他們可能會尋求替代療法或改變生活方式以自然地緩解症狀。此外，消費者對草藥和整體療法的偏好日益成長，也促使他們逐漸放棄傳統制酸劑劑產品，限制了市場成長。消費行為的這種變化給製造商帶來了挑戰，因為他們需要在來自天然保健品的競爭中維持市場佔有率。

全球制酸劑市場趨勢

全球制酸劑市場正呈現出咀嚼片和調味片日益流行的顯著趨勢。隨著消費者尋求更便利、更愉悅的服用方式，傳統的液體和片劑產品正逐漸被口味誘人的創新咀嚼片所取代。這種轉變吸引了更廣泛的消費群體，尤其是年輕消費者，他們希望找到既能緩解胃腸不適又能提升服用體驗的產品。添加口味不僅可以消除制酸劑常見的粉狀口感，還能滿足消費者對便利易用型健康解決方案的普遍偏好，進而推動該品類的市場成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

GlaxoSmithKline plc
Pfizer Inc.
Sanofi
Bayer AG
Johnson & Johnson
Takeda Pharmaceutical Company
Novartis AG
AstraZeneca
Dr. Reddy's Laboratories
Mylan（Viatris）
Teva Pharmaceutical Industries
Pfizer Consumer Healthcare
Boehringer Ingelheim
Abbott Laboratories
Sandoz（Novartis）
Sun Pharmaceutical Industries
Zydus Cadila
Glaxo Wellcome（GSK group）
Prestige Consumer Healthcare
Perrigo Company

結論與建議

簡介目錄

Product Code: SQMIG35H2402

Global Antacids Market size was valued at USD 10.2 billion in 2024 and is poised to grow from USD 10.77 billion in 2025 to USD 16.66 billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).

The global antacids market is poised for significant growth driven by heightened awareness of GERD and the increasing availability of over-the-counter (OTC) antacid medications that provide swift relief from symptoms. The aging population, which is more vulnerable to acid-related disorders, further fuels market demand alongside rising access to dietary information. Shifts in lifestyle habits, including stress, obesity, smoking, and alcohol consumption, contribute to an upsurge in acid-related conditions, challenging healthcare providers. Additionally, the prevalence of serious conditions like Barrett's esophagus among elderly patients elevates the need for various therapeutic approaches, with antacids playing a crucial role. The ongoing popularity of OTC products highlights consumer preferences for quick solutions to heartburn and indigestion, propelling the market forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Antacids market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Antacids Market Segments Analysis

Global Antacids Market is segmented by Type, Formulation, Distribution Channel, End User and region. Based on Type, the market is segmented into Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate and Combination Antacids. Based on Formulation, the market is segmented into Tablets, Liquid / Suspension, Powder, Effervescent Granules and Gummies / Others. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies, Online Pharmacies / E-Commerce, Supermarkets / Hypermarkets and Clinics & Healthcare Centers. Based on End User, the market is segmented into Adults, Geriatric Population, Pediatric Use and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Antacids Market

One of the key market drivers for the global antacids market is the rising prevalence of gastroesophageal reflux disease (GERD) and other related gastrointestinal disorders. The increasing consumption of unhealthy diets, coupled with sedentary lifestyles, has exacerbated the incidence of acid-related conditions, leading to a greater demand for effective relief solutions. Furthermore, the growing awareness of digestive health among consumers is driving the demand for over-the-counter antacids, which provide quick and accessible relief. As healthcare providers continue to emphasize the importance of managing acid-related symptoms, the market for antacids is anticipated to witness significant growth driven by these factors.

Restraints in the Global Antacids Market

One significant market restraint for the global antacids market is the rising awareness regarding potential side effects associated with long-term use of these medications. Consumers are becoming more informed about the risks, such as kidney issues and interference with nutrient absorption, which can prompt them to seek alternative treatments or adopt lifestyle changes to manage symptoms naturally. Additionally, the increasing preference for herbal and holistic remedies is driving a shift away from conventional antacid products, thereby limiting market growth. This shift in consumer behavior poses challenges for manufacturers attempting to maintain their market share amidst growing competition from natural health solutions.

Market Trends of the Global Antacids Market

The global antacids market is witnessing a notable trend towards the increasing popularity of chewable and flavored antacid tablets. As consumers seek more enjoyable and convenient options, there is a discernible shift from traditional liquid and tablet forms to innovative chewable varieties that offer appealing flavors. This transformation caters to a broader demographic, particularly attracting younger consumers who desire products that enhance their experiences while addressing digestive discomfort. The incorporation of flavors not only masks the chalky taste often associated with antacids but also aligns with the broader consumer preference for palatable and user-friendly health solutions, driving market growth in this sector.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2025
PESTEL Analysis
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Technology Assessment
Technology Assessment
Regulatory Landscape

Global Antacids Market Size by Type & CAGR (2026-2033)

Market Overview
Calcium Carbonate
Magnesium Hydroxide
Aluminum Hydroxide
Sodium Bicarbonate
Combination Antacids

Global Antacids Market Size by Formulation & CAGR (2026-2033)

Market Overview
Tablets
Liquid / Suspension
Powder
Effervescent Granules
Gummies / Others

Global Antacids Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies / E-Commerce
Supermarkets / Hypermarkets
Clinics & Healthcare Centers

Global Antacids Market Size by End User & CAGR (2026-2033)

Market Overview
Adults
Geriatric Population
Pediatric Use
Others

Global Antacids Market Size & CAGR (2026-2033)

North America (Type, Formulation, Distribution Channel, End User)
- US
- Canada
Europe (Type, Formulation, Distribution Channel, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Formulation, Distribution Channel, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Formulation, Distribution Channel, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Formulation, Distribution Channel, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. Reddy's Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan (Viatris)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Consumer Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sandoz (Novartis)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zydus Cadila
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glaxo Wellcome (GSK group)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prestige Consumer Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perrigo Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments